Private sector's expanding role in KSA cancer treatment

As the incidence of cancer cases rises in the KSA, there is a need for collaboration between public and private sector enterprises to develop specialized oncology care for patients.

Cancer has become a major public health concern in the Kingdom of Saudi Arabia (KSA). In 2022, data from the Global Cancer Observatory revealed 28,113 reported cases of cancer, resulting in 13,399 deaths. Its incidence in the KSA is predicted to rise by 2050, with an estimated 81,954 cases leading to 50,321 deaths. 

Breast, colorectal, and thyroid cancers are the most prevalent among adults, while leukemia and brain cancers are dominant in children. The volume of patients across the world, and in the KSA, are increasing due to aging population and evolving lifestyles.

The patient pathway for cancer treatment involves several stages, each presenting its unique challenges that can limit equitable access to high-quality care. Patients first visit a general practitioner or specialist with symptoms of cancer. Screenings program that are driven at the national level helps in early detection of cancers. Initial diagnostic tests are conducted, including imaging, blood tests, and biopsies. Based on the test results, patients are referred to an oncologist for further evaluation and treatment planning. A multidisciplinary team collaborates to develop a personalized treatment plan, which may include surgery, chemotherapy, radiotherapy, immunotherapy, or targeted therapy. Regular follow-up appointments, imaging, and lab tests are conducted to monitor treatment response and detect any recurrence. Palliative care is integrated to manage symptoms and improve the quality of life for patients with advanced cancer.

However, there are several challenges along the patient pathway. Delays in recognizing symptoms and accessing initial diagnostic tests can lead to late-stage diagnoses. Limited availability of oncology specialists can delay referrals, and the lack of awareness and regular screening programs, especially for high-risk populations, further hamper early diagnosis. Other challenges include the high cost of chemotherapy medications, limited access to cutting-edge treatments and clinical trials, and instances of treatment discontinuation before completion.

The Ministry of Health (MoH) and other government hospitals play a significant role in augmenting cancer services in the KSA. However, under Vision 2030, the Saudi Arabian government plans to invest over USD 65 billion to develop the healthcare infrastructure in the KSA, with measures like privatizing health services and insurance. Through the National Transformation Program (NTP), the private sector’s contribution is projected to rise from 40% to 65% of the gross domestic product (GDP) by 2030.

In recent years, the private sector has been playing an increasingly significant role in delivering oncology healthcare services in the Kingdom of Saudi Arabia. As in Riyadh there is National blood and cancer center is dedicated cancer center for diagnosis and treatment for cancers in KSA. Their focus lies on providing comprehensive cancer treatments, addressing the needs of patients with innovative therapies.

Another noteworthy development is the expansion plans of Al Amana group, aiming to establish dedicated Oncology unit in Eastern region, reflecting the private sector's commitment towards addressing the needs of cancer patients and providing them with modern facilities and comprehensive care, all under the supervision of highly qualified medical professionals.

This surge in private sector involvement is further magnified by investments in LINAC machines and PET-CT scans, allowing for an enhanced provision of oncology services to cater to the growing patient demand.

Additionally, The Saudi Minister of Health, Fahad Al-Jalajel, has announced that the Saudi Proton Therapy Center at the Comprehensive Cancer Center in King Fahd Medical City is now ready for operation. This newly completed facility will serve as a valuable addition to the range of cancer services available in KSA.

The growing demand for specialized oncology care, advancements in medical technology, and government initiatives to encourage private sector participation in healthcare in addition to increased private insurance coverage are main drivers for private sector investing in oncology services

Investment in oncology services in the KSA can assume different formats depending on the specific goals and strategies of investors: 

Comprehensive oncology centers: Investors can partner with existing healthcare providers in the KSA to set up dedicated oncology units or centers. This partnership may involve funding the infrastructure, technology and equipment required for comprehensive cancer care.

Satellite clinics: Another option is for investors to collaborate with experienced healthcare professionals to establish private cancer clinics. These state-of-the-art clinics can offer specialized oncology services, ranging from diagnostics and radiotherapy to chemotherapy and supportive care.

Specialized oncology departments in hospitals: There can be specialized departments within hospitals for specific diagnostic, treatment plans and rehabilitation services for oncology patients. 

Cancer support services: The private sector can also help expand infrastructure and resources for cancer patients by offering palliative care centers, rehabilitation facilities, and psychological support services.

Telemedicine and digital health solutions: With higher receptivity to telemedicine and digital health solutions, investors can invest in platforms that offer remote consultations, teleoncology, and digital tools for screening and monitoring cancer patients.

Despite significant progress, the healthcare system still has a long way to go in providing quality healthcare for all citizens. It requires a coordinated effort from all stakeholders, including the government, healthcare professionals, and the private sector.

The oncology care market in the KSA presents tremendous potential for investment opportunities. Factors like the aging population, changing lifestyles, and improved cancer detection and screening lead to a higher demand for specialized oncology services. While the Saudi Arabian government is consistently taking steps to improve cancer care, advanced facilities and technologies are needed to further develop oncology services.

To address the existing gaps, effective collaboration of public and private entities is crucial. The private sector can contribute by investing in healthcare infrastructure and services.

A hub and spoke model can help cancer patients with enhanced accessibility to medical services in both tier 1 and tier 2 cities. Additionally, it is helpful in streamlining the referral process, reducing the burden of travel for patients seeking specialized cancer care and promoting interdisciplinary collaboration between healthcare providers in different locations.

JLL Healthcare offers comprehensive real estate and facilities solutions for hospitals, medical professionals, and healthcare investors in the KSA. We assist clients across the care continuum, from planning and financing to buying, leasing, and managing their facilities. Our team leverages deep industry expertise and cutting-edge data analytics to deliver optimal solutions. Learn more.